JFG Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$481K Buy
2,077
+59
+3% +$12K 0.09% 47
2025
Q2
$375K Hold
2,018
0.08% 47
2025
Q1
$423K Sell
2,018
-286
-12% -$55.6K 0.1% 53
2024
Q4
$409K Hold
2,304
0.09% 64
2024
Q3
$455K Buy
2,304
+178
+8% +$33.2K 0.12% 46
2024
Q2
$365K Buy
+2,126
New +$352K 0.1% 41
2020
Q4
Sell
-3,000
Closed -$263K 46
2020
Q3
$263K Buy
+3,000
New +$282K 0.19% 26

Other funds holding ABBV

JFG Wealth Management's ABBV Position: Q3 2025 in Review

JFG Wealth Management increased its AbbVie (ABBV) stake by 2.9% in Q3 2025, buying an estimated $12K and bringing the position to 2,077 shares worth $481K. The position accounts for 0.09% of the portfolio, ranked #47.

JFG Wealth Management first reported a position in ABBV in Q3 2020 and has held it in 7 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • JFG Wealth Management held 2,077 shares of AbbVie worth $481K as of Q3 2025.
  • JFG Wealth Management bought 59 AbbVie shares in Q3 2025, an estimated $12K.
  • AbbVie made up 0.09% of JFG Wealth Management's portfolio in Q3 2025, its #47 holding.
  • JFG Wealth Management first reported a position in AbbVie in Q3 2020 and has held it in 7 quarters since.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on JFG Wealth Management's 13F filing for Q3 2025, filed 31 Oct 2025.